Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Muenchen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Anticancer Research|August 15, 1998
Enhanced immune system activation after treatment with novel antineoplastic platinum agentsH J Muenchen, S K Aggarwal
Critical Reviews in Eukaryotic Gene Expression|January 29, 2000
The role of the nuclear matrix in cancer chemotherapyH J Muenchen, K J Pienta
Anti-Cancer Drugs|December 13, 1997
Activation of murine peritoneal macrophages after cisplatin and taxol combinationH J Muenchen, S K Aggarwal
Anti-Cancer Drugs|March 10, 1998
Immune system activation by cisplatin and its analog 'poly-plat': an in vitro and in vivo studyH J Muenchen, S K Aggarwal
Urology|February 22, 2001
Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3H J Muenchen, P J Poncza, K J Pienta
Anti-Cancer Drugs|April 1, 1997
Enhanced immunostimulation by novel platinum anticancer agentsH J Muenchen, S K Aggarwal, H K Misra, et al.
The Prostate|August 22, 2000
Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental studyJ F Williams, H J Muenchen, J M Kamradt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor"H J Muenchen, D L Lin, M A Walsh, et al.
Anticancer Research|May 16, 2000
The study of gemcitabine in combination with other chemotherapeutic agents as an effective treatment for prostate cancerH J Muenchen, M M Quigley, M J Pilat, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anticancer Research|August 15, 1998
Enhanced immune system activation after treatment with novel antineoplastic platinum agentsH J Muenchen, S K Aggarwal
Critical Reviews in Eukaryotic Gene Expression|January 29, 2000
The role of the nuclear matrix in cancer chemotherapyH J Muenchen, K J Pienta
Anti-Cancer Drugs|December 13, 1997
Activation of murine peritoneal macrophages after cisplatin and taxol combinationH J Muenchen, S K Aggarwal
Anti-Cancer Drugs|March 10, 1998
Immune system activation by cisplatin and its analog 'poly-plat': an in vitro and in vivo studyH J Muenchen, S K Aggarwal
Urology|February 22, 2001
Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3H J Muenchen, P J Poncza, K J Pienta
Anti-Cancer Drugs|April 1, 1997
Enhanced immunostimulation by novel platinum anticancer agentsH J Muenchen, S K Aggarwal, H K Misra, et al.
The Prostate|August 22, 2000
Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental studyJ F Williams, H J Muenchen, J M Kamradt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor"H J Muenchen, D L Lin, M A Walsh, et al.
Anticancer Research|May 16, 2000
The study of gemcitabine in combination with other chemotherapeutic agents as an effective treatment for prostate cancerH J Muenchen, M M Quigley, M J Pilat, et al.
Pageof 1